港股異動 | 廣汽集團(2238.HK)升超5% 新車上市值得期待
格隆匯12月2日丨廣汽集團(2238.HK)今日股價明顯上漲,現升5.14%,報8.79港元,暫成交4732萬港元,最新總市值900億港元。A股廣汽集團則漲近1%。日前售價16.98-23.98萬元,廣汽本田皓影正式上市。作為一款全新的SUV車型,採用全新設計方案的皓影無疑會更能吸引年輕消費者的關注。瑞銀稱,廣汽集團新車型使業績增長前景變得明朗。目標價由13.2港元上調到13.9港元,維持買入。在車市下行壓力下,廣汽本田交出了自己的“成績單”:今年1-10月累計銷量近64萬輛,同比增長7.18%,表現異常搶眼。廣汽本田副總經理袁小華表示,明年將挑戰同比增長5%的目標。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.